Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
Reset 

AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI(TM) (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis

NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved SKYRIZI(TM) (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  AbbVie Inc.

The erectile dysfunction (ED) drugs market will register a CAGR of over 4% by 2023

NEW YORK, April 23, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2019

Global medical sensor market is expected to grow with a CAGR of 9.52% over the forecast period from 2019-2025

NEW YORK, April 23, 2019 /PRNewswire/ -- The report on the global medical sensor market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019

Vessel Sealing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

NEW YORK, April 23, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2019

VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  VitalHub Corporation

Akari Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Akari Therapeutics Plc

Merit Medical Reports Earnings for Quarter Ended March 31, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Merit Medical Systems, Inc.

Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Galapagos NV

NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  NeoChord, Inc.

Diversicare to Announce First Quarter 2019 Financial Results on Thursday, May 2, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019

Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Myriad Genetics, Inc.

Stryker reports first quarter 2019 operating results

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Stryker Corporation

ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  ReWalk Robotics Ltd.

Retrophin to Report First Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Retrophin, Inc

Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Harvard Bioscience, Inc.

Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend

Read more ››
By: Nasdaq / GlobenewsWire - 23 Apr 2019
Related companies:  Psychemedics Corporation

Jazz Pharmaceuticals to Report 2019 First Quarter Financial Results on May 7, 2019

DUBLIN, April 23, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2019 first quarter financial results on Tuesday, May 7, 2019, after the close of the financial markets. Company management will host a live audio webcast immediately following... Read more ››

By: PR Newswire Association LLC. - 23 Apr 2019
Related companies:  Jazz Pharmaceuticals plc

Bluegrass Farmaceuticals signs entertainment icon Nelly as strategic partner: Changing the way the world consumes botanical therapeutics

BELTON, Ky., April 23, 2019 /PRNewswire/ -- Bluegrass Farmaceuticals, a botanical therapeutics company, announced today... Read more ››

By: PR Newswire Association LLC. - 23 Apr 2019

Medicine Man Technologies Inc. Names Co-Founder Andy Williams as Chief Executive Officer

DENVER, April 23, 2019 /PRNewswire/ -- Medicine Man Technologies Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated operator, announced that the Company has named Co-Founder Andy Williams as Chief Executive Officer after serving as interim... Read more ››

By: PR Newswire Association LLC. - 23 Apr 2019

WINDGO Granted Nano-Tech Vehicular Neurology Patent

COLUMBIA, Mo., April 23, 2019 /PRNewswire/ -- WINDGO, Inc., a research and development company specializing in smart material and vibrational transfer technologies, announced today that they have been granted US Patent No. 10,266,139 for technology that is designed to proactively and... Read more ››

By: PR Newswire Association LLC. - 23 Apr 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑